When Deepinder Goyal, founder and CEO of Eternal (Zomato’s parent company), began appearing in public wearing a small metallic device near his temple, it triggered widespread curiosity across tech and startup circles. The gadget, now widely referred to as “Temple,” is being positioned by Goyal as an experimental brain-health wearable designed to track signals linked to cerebral blood flow continuously and in real time.
But Temple is only one part of a much larger idea Goyal has been quietly building around ageing, gravity, and long-term human health.
Over the past few months, Goyal has been “soft launching” a personal research initiative called Continue Research. He has described it publicly as neither a startup nor a conventional company, but a research-driven effort supported by a privately backed fund, aimed at exploring new ideas around longevity. He has also indicated that the work and findings are intended to remain open and research-oriented, rather than immediately commercial.
At the centre of this initiative is what Goyal calls the “Gravity Ageing Hypothesis.” In a LinkedIn post introducing the idea, he wrote: “Newton gave us a word for it. Einstein said it bends spacetime. I am saying gravity shortens lifespan.”
In the same post, he suggested that gravity and a lifetime of upright posture may play an under-examined role in ageing, particularly by influencing how blood circulates to the brain over decades.
This framing has drawn attention not only because of the ambition of the claim, but also because of the unusual crossover between a food-tech entrepreneur and a highly specialised area of human physiology.
What is “Temple,” according to recent reporting and his posts?
Across recent media coverage and Goyal’s own social posts, Temple is consistently described as a small, head-worn sensor placed near the temple or forehead. It is repeatedly referred to as an experimental wearable rather than a finished consumer gadget, and is presented as a device intended to monitor or estimate cerebral blood flow–related activity continuously and in real time. The device is also closely linked to Goyal’s research work on gravity, posture, and ageing.
Goyal has teased the device online with captions like “Getting there,” which many have interpreted as a signal of an early-stage or limited rollout rather than a commercial launch. So far, there has been no public announcement of pricing, consumer availability, regulatory classification, or medical approval.
How could this kind of technology work?
Temple’s internal design and methodology have not yet been publicly detailed. However, people familiar with brain-monitoring technologies say that non-invasive cerebral blood flow tracking is an active field of research worldwide, and that devices attempting this generally draw from a few established scientific approaches.
In research and clinical settings, brain blood flow and hemodynamics are commonly studied using methods such as transcranial Doppler ultrasound, which uses ultrasound waves to measure blood flow velocity in major brain arteries. Optical monitoring techniques, such as functional near-infrared spectroscopy, use near-infrared light to track changes in blood oxygenation and circulation in the cortex. Diffuse correlation spectroscopy is another optical method used in laboratories to estimate microvascular blood flow.
Based on how Temple is worn and described, experts speculate it may be attempting some form of optical sensing, where light is transmitted through superficial tissues and analysed for blood-flow-related signals. Such approaches already exist in research-grade “wearable brain imaging” systems internationally. However, without disclosed specifications or published validation, these remain informed speculation, not confirmation.
What does Goyal claim Temple could enable?
Goyal’s public comments link Temple directly to his gravity-ageing idea. The underlying premise is that if cerebral blood flow–related signals can be continuously monitored in everyday life, researchers may be able to observe how posture, activity, rest, and possibly gravity-related stress affect long-term brain perfusion.
He suggests that such patterns could eventually help explain mechanisms behind ageing and cognitive decline, and possibly guide new preventive approaches. In simple terms, Temple is being positioned not as a fitness tracker, but as a tool to generate data for studying how the brain is supplied with blood over long periods of time.
What does science say about gravity and brain blood flow?
Gravity and posture are already recognised in medical science as factors that influence circulation. There is extensive physiological research on how cerebral blood flow changes when humans move from lying down to standing, how the cardiovascular system adapts to gravity, and how altered gravity environments, such as spaceflight or head-down tilt studies, affect brain perfusion. These areas are actively studied in neurology, cardiology, and aerospace medicine.
Where controversy arises is in extending this into a broad claim about gravity being a primary driver of ageing. Most mainstream ageing research focuses on cellular damage, metabolism, genetics, inflammation, and environmental factors. While circulation is undeniably important, experts caution against oversimplifying ageing into a single dominant cause without strong longitudinal and clinical evidence.
Medical reaction and expert caution
Doctors and clinicians quoted in recent coverage have urged caution. Several have pointed out that accurately measuring cerebral blood flow is technically complex and usually relies on validated medical equipment. Continuous monitoring in healthy people is still largely a research-level activity, not a consumer health standard. No publicly available data yet demonstrates that Temple’s readings are clinically reliable, medically validated, or meaningful for diagnosing or preventing disease.
Some medical professionals have been blunt in warning the public not to treat early prototypes or experimental wearables as proven health tools.
Is Temple a product or an experiment?
Based on what is publicly known today, Temple is best described as an experiment first, and a product only potentially later.
This is because it is repeatedly referred to as experimental in coverage, there is no published validation data, regulatory pathway, or defined medical or consumer use case, and Goyal himself has framed his broader initiative as research-driven rather than startup-driven.
At the same time, the public showcasing of the device and the “coming soon” tone suggest that some form of limited release or structured trial could emerge in the future.
What would make Temple scientifically credible?
If Temple is to move beyond curiosity and into serious health-tech territory, experts say several milestones would matter. These include clear disclosure of what exactly is being measured and how, independent validation studies comparing it to established methods, peer-reviewed research rather than only social posts, transparent positioning as either a wellness wearable or a medical device, and evidence of real-world relevance, not just data collection.
Until then, Temple remains a high-profile, founder-led experiment sitting at the intersection of longevity research, wearable technology, and a controversial, as-yet unproven hypothesis about gravity and ageing.
About the Author
